Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-906-2 | CAS number: 22450-96-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Under the conditions of the studies performed the following outcomes were determined for SABoTBA:
Skin irritation: predicted to be non-irritant to the skin
Eye irritation: predicted to be non-corrosive/non-severe irritant to the eye
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07 to 13 May 2013 (in-life dates)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline (OECD 439) compliant study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- human
- Strain:
- other: human epidermis skin constructs
- Details on test animals or test system and environmental conditions:
- The 'EPISKIN™ Skin Irritation Test 15 Min - 42 Hours' using human epidermis skin constructs, supplied by SkinEthic Laboratories, Lyon, France, has been accepted as a replacement to the in vivo test, Draize Skin Irritation Test, by the European Centre for the Validation of Alternative Methods (ECVAM, 2007). The test was conducted in accordance with the Standard Operating Procedure, In Vitro Skin Irritation Test: Human Epidermis Model (L’Oreal 2009), supplied by L’Oreal (leading laboratory in the validation of the test for ECVAM) and the OECD 439 Guideline For The Testing of Chemicals: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method (OECD 439).
The test involves the application of the test substance for 15 minutes to the EPISKIN™ three-dimensional human skin model. The model consists of normal, human-derived epidermal keratinocytes which have been seeded on a dermal substitute consisting of a collagen type 1 matrix coated with type IV collagen. After 13 days in culture a multilayered, highly differentiated model of the human epidermis with a functional multi-layered stratum corneum has formed. The epidermis surface area supplied is 0.38cm2. The EPISKIN™ kits include assay medium, maintenance medium, 12 well plates and the tissues which are shipped on nutritive agar.
The principle of the assay is that irritant substances are sufficiently cytotoxic to cause cell death in the cell layers. The cell viability was determined by mitochondrial dehydrogenase activity, assessed by the reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide) to a soluble, coloured, formazan product. The prediction model (OECD 439) uses the percentage viability values (compared to negative control viability) to identify irritant and non-irritant substances. The test includes acceptance criteria for both negative and positive controls. - Type of coverage:
- open
- Preparation of test site:
- other: surface wetted prior to application
- Vehicle:
- water
- Controls:
- no
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 ± 2mg was dispensed over each tissue
VEHICLE
- Amount(s) applied (volume or weight with unit): 5 µL of purified water prior to application of the test substance. - Duration of treatment / exposure:
- 15 min (±0.5min) contact time with the test substance, followed by rinsing and then 42 h (±1 h) incubation time at 37 ± 2°C in a humidified atmosphere of 5% CO2 in air.
- Details on study design:
- Tissue
The tissues are received as a kit, the kit contents were checked and the inserts with tissues on agarose were stored at room temperature until use. The kit was used within the expiry date indicated by the supplier (expiry date: 13 May 2013). The maintenance medium was pre-warmed to 37ºC. The tissues were removed from the agar and placed into wells of 12 well plates containing 2 mL pre-warmed maintenance medium per well. The tissues were incubated for a minimum of 24 hours at 37 ± 2°C in a humidified atmosphere of 5% CO2 in air.
Application
A weight of 10 ± 2mg was dispensed over each tissue, the tissues were wetted with 5 µL of purified water prior to application of the test substance. The positive (5% Sodium Dodecyl Sulphate (SDS) in purified water) and negative (sterile Dulbecco’s Phosphate Buffered Saline (DPBS) with magnesium and calcium) controls were in liquid form and were applied by dispensing a volume of 10 µL over each tissue using a positive displacement pipette.
Procedure
After incubation for at least 24 hours in maintenance medium, triplicate tissues were dosed for 15 ± 0.5 minutes with the test substance, negative or positive control at room temperature. The test substance was spread over the surface of the tissues with a curved spatula. A maximum of four samples were applied in a block with a minimum of 1 minute intervals between each application of substance. On application of 10 µL, the positive control was spread over the tissue for approximately 30 seconds and then respread with a curved flat spatula after 7 minutes (actual time 8 minutes) application time.
After 15 ± 0.5 minutes, each tissue was rinsed with 25 mL sterile Dulbecco’s Phosphate Buffered Saline (DPBS) to remove residual test substance. Inserts were then blotted on absorbent paper to remove remaining DPBS. Each insert was then transferred to a well containing 2 mL maintenance medium and incubated for 42 ± 1 hour at 37 ± 2°C in a humidified atmosphere of 5% CO2 in air.
After 42 ± 1 hour, each insert was transferred to a well containing 2 mL of 0.3 mg/mL MTT ((3-(4,5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide)) and incubated for 3 hours ± 5 minutes at 37 ± 2°C in a humidified atmosphere of 5% CO2 in air.
At the end of 3 hours ± 5 minutes, the triplicate inserts were blotted on absorbent paper. The epidermis was removed from the insert using a biopsy punch, the epidermis separated from the collagen matrix using forceps and both parts placed in a micro tube.
When all tissues had been punched, the tissues were vortexed with 500 µL of acidic isopropanol (0.04 N HCl final concentration).
The tissues were extracted by storing at 2-8 ºC, protected from light, for 48 - 70 hours.
After formazan extraction, duplicate 200 µL aliquots of the extractant from each micro tube were pipetted into the wells of flat-bottomed 96-well plates. The extractant was mixed by vortexing prior to taking the aliquots. The absorbance was read at 540 nm, with six wells containing acidified isopropanol (0.04 N HCl final concentration) as a blank. - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 97.2
- Remarks on result:
- no indication of irritation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- It was concluded that the test substance, SABoTBA, with a mean tissue viability of 97.2 ± 4.7%, was predicted as non-irritant to the skin.
- Executive summary:
The study was performed to assess the skin irritation potential, in vitro, of the test substance,SABoTBA in accordance with the OECD Guideline 439.
The test substance was applied to EPISKIN™human epidermis skin constructs. The constructs consisted of normal, human-derived epidermal keratinocytes, which had been cultured to form a multilayered, highly differentiated model of the human epidermis with a functional multilayered stratum corneum. The cell viability was determined by mitochondrial dehydrogenase activity, assessed by the reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5‑diphenyltetrazolium bromide) to a soluble, coloured, formazan product. The prediction model (OECD Guideline 439) uses the percentage viability values (compared to negative control viability) to identify irritant and non-irritant substances.
The test substance,SABoTBA, elicited a mean tissue viability of 97.2 ± 4.7% and was predicted as non-irritant to the skin.
Reference
Table 1: EPISKIN study data
Sample |
Tissue replicate |
Optical Density (OD) |
OD - blank |
% Negative Control |
Negative control |
a |
1.071 1.054 |
0.927 0.910 |
100.6 |
b |
1.059 1.018 |
0.915 0.874 |
97.9 |
|
c |
1.087 1.055 |
0.942 0.911 |
101.5 |
|
|
Mean SD |
0.913 0.023 |
100.0 1.8 |
|
Positive control |
a |
0.569 0.542 |
0.425 0.398 |
45.0 |
b |
0.431 0.445 |
0.286 0.301 |
32.2 |
|
c |
0.510 0.470 |
0.366 0.326 |
37.9 |
|
|
Mean SD |
0.350 0.055 |
38.4 6.5 |
|
SABoTBA |
a |
1.072 1.027 |
0.928 0.883 |
99.1 |
b |
1.014 0.952 |
0.870 0.808 |
91.9 |
|
c |
1.093 1.033 |
0.949 0.888 |
100.6 |
|
|
Mean SD |
0.887 0.049 |
97.2 4.7 |
|
Blank |
|
0.135 0.149 0.150 0.140 0.145 0.146 |
|
|
Mean SD |
0.144 0.006 |
The mean Optical Density (OD) for the six replicate blanks was subtracted from the individual substance and control tissues OD.
The viability of each tissue was expressed as a percentage of the mean negative control value.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14-16 May 2013 (in-life dates)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline (OECD 437) compliant study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- other: bovine
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- The bovine eyes, supplied by Joseph Morris Abattoir, were excised by an abattoir employee and collected as soon after slaughter as possible (excised at 12.40 hours, 14 May 2013). Instructions were given to avoid damaging the corneas during excision. Excised eyes were maintained and transported to the laboratory, at ambient temperature, in sufficient HBSS, containing 1% (v/v) penicillin/streptomycin solution, to cover all the eyes in the receptacle. The eyes were used within 4 hours of slaughter (incubation of mounted corneas commenced at 14.41 hours, 14 May 2013).
- Vehicle:
- physiological saline
- Controls:
- no
- Amount / concentration applied:
- 750 µL of a 20% w/w solution in 0.9% sodium chloride
- Duration of treatment / exposure:
- 4h (± 5 min)
- Number of animals or in vitro replicates:
- 3 corneas per treatment group
- Details on study design:
- Preparation of corneas
All eyes were carefully examined, macroscopically, for defects (opacity, scratches, pigmentation, cuts, etc.) and those exhibiting defects were discarded. The tissue surrounding the eyeball was carefully pulled away and the cornea dissected leaving approximately 2 to 3 mm of sclera present around the cornea. The isolated corneas were stored in a petri dish containing HBSS plus 1% penicillin/streptomycin solution until all the corneas had been dissected. Once all the corneas had been dissected, they were rinsed in fresh HBSS plus 1% penicillin/streptomycin solution prior to mounting.
The corneas were mounted in the cornea holders with the endothelial side against the O-ring of the posterior half of the holder. Each cornea was gently flattened over the O-ring and holder surface with a wetted, gloved finger to expel any air. The anterior half of the holder was then positioned on top of the cornea and secured with screws. Both compartments of the holder were filled with HBSS plus 1% penicillin/streptomycin, using a syringe. The posterior compartment was always filled first to return the cornea to its natural shape. Care was taken to ensure no air bubbles were present within the holders. The holders were then plugged and incubated, in an upright position, overnight at room temperature (approximately 20°C).
After overnight incubation at room temperature (approximately 20°C) the HBSS plus 1% penicillin/streptomycin was removed from both chambers. Both chambers were filled with cMEM (posterior chamber first), taking care to exclude air bubbles and plugged. The corneas were then incubated in the upright position for 60 minutes ± 5 minutes at 32°C± 1°C in a waterbath. The waterbath temperature remained within the limits of 32°C ± 1°C throughout the experiment.
At the end of the 60 minute incubation period, the medium was removed from both the anterior and posterior compartments using a pipette tip attached to a vacuum pump. The compartments were refilled with fresh cMEM (posterior chamber first). Again care was taken to ensure no air bubbles were present within the holders. The posterior compartment was then plugged and the basal opacity measurements performed.
Opacity measurement
The opacitometer measured the light transmission through the centre of each mounted cornea, displaying a numerical opacity value (arbitrary unit). The opacity of each cornea was measured by reading each holder in the right-hand chamber of the calibrated opacitometer. Corneas with an opacity value greater than 7 units were discarded. The mean basal opacity value of the corneas was then calculated and three corneas with opacity values close to the mean value were chosen for use as negative control corneas.
Treatment groups
Corneas were treated in triplicate with either the test substance, positive control (imidazole) or negative control (0.9% sodium chloride solution).
Treatment of corneas
The test substance, SABoTBA, a white crystalline powder, and the positive control material (imidazole) were tested at 20% (w/w) in 0.9% sodium chloride solution. The test substance was mixed during preparation using a mortar and pestle. The 0.9% sodium chloride solution was added to achieve the desired concentration.
Immediately prior to treatment, the medium was removed from the anterior compartment of the holder using a pipette tip attached to a vacuum pump, taking extra care to ensure all excess liquid had been removed. Seven hundred and fifty µL (750 µL) of test substance, negative control (0.9% sodium chloride solution) or positive control material (imidazole 20% w/w solution) was introduced in to the anterior part of the holder. The test substance at 20% w/w formed a white suspension and was added to the anterior compartment using a 1 mL syringe via the top port. Following application the anterior compartment was plugged. The holder was slightly rotated to ensure uniform distribution of the test substance over the surface of the cornea. Each holder was incubated in a horizontal position at 32°C ± 1°C for 4 hours ± 5 minutes in a waterbath.
Following incubation, the test substance, positive and negative controls were removed and the epithelial surface of the cornea washed, at least three times or until the wash medium (EMEM with phenol red) was clear and there was no discolouration. The wash medium was added via the holes on the top of the holder. After each wash, the wash medium was removed using a pipette tip attached to a vacuum pump. The corneas were gently rinsed with the wash medium until the medium was clear and the colour unchanged. The corneas treated with the test substance required 7 washes. Following completion of the wash step, the medium was removed from both compartments and re-filled with fresh cMEM. The posterior compartment was re-plugged and the opacity of each cornea measured and recorded. The opacity values obtained at this stage were used in calculating the final In Vitro Irritancy Score.
Throughout the assay the corneas were examined for opaque spots or other irregularities. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- mean
- Value:
- 1.4
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance, SABoTBA, elicited an In Vitro Irritancy Score of 1.4 ± 1.5 and was predicted to be a non-corrosive/non-severe eye irritant.
- Executive summary:
The Bovine Corneal Opacity and Permeability Assay (BCOP) was performed to assess the ocular irritancy potential in vitro of the test substance, SABoTBA. Imidazole was tested in parallel as a positive control.
The assay used isolated bovine corneas to assess the ocular corrosivity or severe irritancy potential of the test substance in vitro. The isolated corneas were obtained as a by-product of the meat production industry. Two endpoints, corneal opacity and permeability, were measured and combined to give an In Vitro Irritancy Score which was used to classify the test substance as potential eye irritants according to OECD Guideline 437.
The test substance,SABoTBA, elicited an In Vitro Irritancy Score of 1.4 ± 1.5 and was predicted to be a non-corrosive/non-severe eye irritant.
Reference
Summary of results
Sample |
Opacity ± SD |
Permeability |
In vitro irritancy Score |
In vitro |
SABoTBA |
1.000 ± 1.000 |
0.025 ± 0.038 |
1.4 ± 1.5 |
Non-corrosive/Non-severe irritant |
Imidazole |
126.333 ± 24.583 |
3.212 ± 0.563 |
174.5 ± 17.6 |
Corrosive/Severe irritant |
0.9% saline |
0.000 ± 0.000 |
0.078 ± 0.004 |
NA |
NA |
Assay validity
The positive control, imidazole,elicited an In Vitro Irritancy Score of 174.5. This value was within the historical range (mean ± 2 x SD 126.0 – 185.4) for the assays performed to date.
The negative control, 0.9% saline, opacity mean change value was 0.000 which was below the maximum acceptance value of 3.0. The permeability mean of the negative control was 0.078 which was below the maximum acceptance value of 0.1.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation
The study was performed to assess the skin irritation potential, in vitro, of the test substance,SABoTBA in accordance with the OECD Guideline 439.
The test substance was applied to EPISKIN™human epidermis skin constructs. The constructs consisted of normal, human-derived epidermal keratinocytes, which had been cultured to form a multilayered, highly differentiated model of the human epidermis with a functional multilayered stratum corneum. The cell viability was determined by mitochondrial dehydrogenase activity, assessed by the reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5‑diphenyltetrazolium bromide) to a soluble, coloured, formazan product. The prediction model (OECD Guideline 439) uses the percentage viability values (compared to negative control viability) to identify irritant and non-irritant substances.
The test substance,SABoTBA, elicited a mean tissue viability of 97.2 ± 4.7% and was predicted as non-irritant to the skin.
Eye irritation
The Bovine Corneal Opacity and Permeability Assay (BCOP) was performed to assess the ocular irritancy potential in vitro of the test substance, SABoTBA. Imidazole was tested in parallel as a positive control.
The assay used isolated bovine corneas to assess the ocular corrosivity or severe irritancy potential of the test substance in vitro. The isolated corneas were obtained as a by-product of the meat production industry. Two endpoints, corneal opacity and permeability, were measured and combined to give an In Vitro Irritancy Score which was used to classify the test substance as potential eye irritants according to OECD Guideline 437.
The test substance,SABoTBA, elicited an In Vitro Irritancy Score of 1.4 ± 1.5 and was predicted to be a non-corrosive/non-severe eye irritant
Justification for selection of skin irritation / corrosion endpoint:
Key study, GLP/Guideline compliant study
Justification for selection of eye irritation endpoint:
Key study, GLP/Guideline compliant study
Justification for classification or non-classification
In accordance with EU CLP (Regulation (EC) No. 1272/2008), classification is not required for skin/eye irritation based on the available data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.